SS
ACHV icon

SBI Securities’s Achieve Life Sciences ACHV Stock Holding History

SBI Securities’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.9K Buy
14,841
+732
+5% +$3.49K ﹤0.01% 929
2026
Q1 		$41.5K Buy
14,109
+68
+0.5% +$302 ﹤0.01% 1173
2025
Q4 		$69.8K Buy
14,041
+1
+0% +$4 ﹤0.01% 961
2025
Q3 		$44.2K Buy
14,040
+17
+0.1% +$47 ﹤0.01% 1137
2025
Q2 		$31.7K Hold
14,023
– – ﹤0.01% 1235
2025
Q1 		$37.4K Hold
14,023
– – ﹤0.01% 1085
2024
Q4 		$49.4K Buy
+14,023
New +$63.5K ﹤0.01% 994

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SBI Securities's ACHV Position: Q2 2026 in Review

SBI Securities increased its Achieve Life Sciences (ACHV) stake by 5.2% in Q2 2026, buying an estimated $3.49K and bringing the position to 14,841 shares worth $96.9K. The position accounts for ﹤0.01% of the portfolio, ranked #929.

SBI Securities first reported a position in ACHV in Q4 2024 and has held it in 7 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • SBI Securities held 14,841 shares of Achieve Life Sciences worth $96.9K as of Q2 2026.
  • SBI Securities bought 732 Achieve Life Sciences shares in Q2 2026, an estimated $3.49K.
  • Achieve Life Sciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #929 holding.
  • SBI Securities first reported a position in Achieve Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.